Key result
Percutaneous transluminal coronary angioplasty successfully reduced coronary stenosis to <50% and resolved silent myocardial ischemia in all 8 treated children with Kawasaki disease.
Why the study?
Does PTCA improve silent myocardial ischemia and reduce coronary stenosis in children with Kawasaki disease?
Population
8 asymptomatic children with Kawasaki disease, coronary stenosis >25%, and a positive dobutamine stress…
Design
Case_series
Follow-up
6 months
Authors
Loading...
Hypothesis-generating for PTCA in Kawasaki silent ischemia; prospective trials needed before clinical adoption.
Observational (n=8)
Does PTCA improve silent myocardial ischemia and reduce coronary stenosis in children with Kawasaki disease?
PTCA is effective in dilating stenotic coronary arteries and resolving silent myocardial ischemia in children with Kawasaki disease.
Ogawa et al. (1997) conducted an observational in Kawasaki disease with silent myocardial ischemia (n=8). Percutaneous transluminal coronary angioplasty (PTCA) was evaluated on Reduction of coronary artery stenosis to <50% and absence of myocardial ischemia. Percutaneous transluminal coronary angioplasty successfully reduced coronary stenosis to <50% and resolved silent myocardial ischemia in all 8 treated children with Kawasaki disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: